Large Biotech Streamlines Investigator’s Brochures with Certara’s Project Management Expertise Case Study Large Biotech Streamlines Investigator’s Brochures with Certara’s Project Management Expertise Learn how Certara's project management team helped a large biotech streamline the development and updates…CertaraSeptember 5, 2025
Clinical Trials Regulation (EU) No. 536/2014 – The Impact on Annual Safety Reporting Blog Clinical Trials Regulation (EU) No. 536/2014 – The Impact on Annual Safety Reporting Stay compliant with EU rules for the pharmaceutical industry. Learn about annual safety reports and…CertaraSeptember 5, 2025
Certara Biotech Forum: Workshop on Developing Investor-Ready Strategies Live Events Certara Biotech Forum: Workshop on Developing Investor-Ready Strategies CertaraSeptember 4, 2025
The Pursuit of Certainty: Integrated Evidence and the evolving drug development and reimbursement landscape Webinar The Pursuit of Certainty: Integrated Evidence and the evolving drug development and reimbursement landscape CertaraSeptember 3, 2025
Blueprint for Biotech Success: De-risking Early Development to Secure Long-Term Value On-Demand Webinar Blueprint for Biotech Success: De-risking Early Development to Secure Long-Term Value Discover strategies to cut risk, speed timelines, and boost investor confidence in early biotech development.CertaraAugust 21, 2025
The Many Challenges of Patient Narrative Writing | RAPS Sponsored Webinar Webinar The Many Challenges of Patient Narrative Writing | RAPS Sponsored Webinar CertaraAugust 18, 2025
Small Biotech Clinical Trial Application (CTA) & Investigational New Drug (IND) Submission Success with Integrated Project Management Case Study Small Biotech Clinical Trial Application (CTA) & Investigational New Drug (IND) Submission Success with Integrated Project Management Find out how Certara helped a small biotech achieve on-time IND and CTA submissions with…CertaraAugust 18, 2025
Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma Publication Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma Explore comprehensive population pharmacokinetic analyses of belantamab mafodotin, evaluating both monotherapy and combination regimens in…CertaraAugust 13, 2025
Sacituzumab Govitecan Population Pharmacokinetics: Updated Analyses Using HR+/HER2− Metastatic Breast Cancer Data From the Phase 3 TROPiCS‐02 Trial Publication Sacituzumab Govitecan Population Pharmacokinetics: Updated Analyses Using HR+/HER2− Metastatic Breast Cancer Data From the Phase 3 TROPiCS‐02 Trial Explore updated results from the Phase 3 TROPiCS-02 trial of Sacituzumab Govitecan in advanced HR+/HER2–…CertaraAugust 13, 2025